SomaLogic announced today that its United States clinical laboratory (CLIA laboratory) has been re-accredited by the College of American Pathologists (CAP). The successful renewal of CAP accreditation is based on the results of a recent on-site inspection designed to ensure the highest laboratory standards.
Agilent Technologies, Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company) today announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for use in the nucleic acid detection step within SomaLogic’s novel SomaScan assay, a protein measurement platform with applications across basic and clinical research, diagnostics, and pharmaceutical discovery and development.
SomaLogic CEO Roy Smythe, M.D. announced today that Melody Harris has been appointed President of SomaLogic. Ms. Harris joined SomaLogic in April 2018 as Chief Legal Officer from Qualcomm Life, a digital health subsidiary of Qualcomm, where she led global and strategic deals with companies such as Novartis, Philips, Abbvie, United Healthcare, Walgreens, and WebMD as Vice President & Chief Counsel.
SomaLogic, Inc. announced today that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the agreement terms, SomaLogic will analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify and validate protein biomarkers for use by Janssen and SomaLogic in predicting, diagnosing, monitoring, and treating disease.
SomaLogic, Inc., announced today that its new Chief Executive Officer, Roy Smythe, M.D., will present the company’s current status and strategic direction at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Dr. Smythe’s presentation, which is included in the Conference’s “Emerging Markets Track,” is scheduled for Wednesday, January 9, 2019 at 3:00 p.m. Pacific Time.
deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic’s expertise in human proteins with deCODE’s expertise in human genetics. The collaboration combines deCODE’s rich data sets with SomaLogic’s leading protein measurement capabilities to enhance the understanding of how human disease and health are mediated through proteins to influence health outcomes.
The SomaLogic Board of Directors announced today that they have selected Roy Smythe, M.D. as the next Chief Executive Officer of SomaLogic. A trained surgeon and former translational scientist, Dr. Smythe joins SomaLogic from Royal Philips, where he served as Chief Medical Officer for Strategy and Partnerships.
Larry Gold, the founder and chairman of the board of SomaLogic, has been awarded the 8th International Steven Hoogendijk Prize by the Dutch Batavian Society of Experimental Philosophy. The biennial Hoogendijk prize honors global breakthroughs at the cutting edge of medicine and technology.